Literature DB >> 36028312

Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.

.   

Abstract

Entities:  

Year:  2022        PMID: 36028312      PMCID: PMC9417159          DOI: 10.1212/NXI.0000000000200036

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


× No keyword cloud information.
  1 in total

1.  Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod.

Authors:  Virginia Palomares Cabeza; Laura Y L Kummer; Luuk Wieske; Ruth R Hagen; Mariel Duurland; Veronique A L Konijn; Koos P J van Dam; Eileen W Stalman; Carolien E van de Sandt; Laura Boekel; Niels J M Verstegen; Maurice Steenhuis; Theo Rispens; Sander W Tas; Gertjan Wolbink; Joep Killestein; Taco W Kuijpers; S Marieke van Ham; Filip Eftimov; Anja Ten Brinke; Zoé L E van Kempen
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.